Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3183 of 6351
-
Can a Heart-to-Heart talk keep dialysis patients on track?
Disease control OngoingMoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group r…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a sleep drug boost brain power in seniors?
Symptom relief CompletedThe goal of this study is to examine the impact of suvorexant, an FDA-approved insomnia medication, on daytime symptoms (as measured by the Daytime Insomnia Symptoms Scale: cognition, positive mood, negative mood, and fatigue/sleepiness) among older adults with insomnia. The prim…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New scan could reveal hidden heart attack triggers
Diagnosis Recruiting nowThe Primary Objective is to determine if a new nuclear tracer (named 18F-Florbetaben) used with nuclear imaging (PET imaging) can detect inflamed plaque in patients with recent ACS or stroke/TIA.
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
AI reads brain scans to predict memory training success
Knowledge-focused Recruiting nowThis study will train a machine learning tool to predict response to a cognitive training intervention using baseline brain MRI sequences from older adults with amnestic mild cognitive impairment.
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New computer model could predict cerebral palsy in babies
Knowledge-focused Recruiting nowThe goal of this observational study is to create a computer model to help doctors predict any problems occurring during development of babies after being diagnosed with brain injury. This will help provide better care to future babies. Next to this, the experiences of parents or…
Sponsor: dr. M.J.N.L. Benders • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Could a tropical berry boost immunotherapy for kidney cancer?
Disease control OngoingThis phase I trial tests the safety, side effects, and best dose of camu camu when used in combination with nivolumab and ipilimumab in treating patients with kidney cancer that has spread to other places in the body. A monoclonal antibody is a type of protein that can bind to ce…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Simple handgrip exercise may cut clot risk for PICC patients
Prevention By invitation onlyPatients who have a peripherally-inserted central catheter (PICC) placed are at a risk of developing a deep vein thrombosis (DVT). At TriHealth, approximately 2-4 patients per month who have a PICC placed experience a subsequent DVT. One innovative way to possibly mitigate the ri…
Sponsor: TriHealth Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Can a PTSD app boost alcohol recovery?
Symptom relief OngoingThe purpose of this study is to learn whether a mobile health application (mHealth App) for posttraumatic stress disorder (PTSD) with brief support can help individuals who are in treatment for alcohol problems.
Sponsor: Michigan State University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New vaccine strategy could shield lymphoma survivors from pneumonia
Vaccine OngoingTo compare the effects of a pneumococcal vaccine called PCV20 when given as a single dose versus a boosted regimen to patients who previously received anti-CD20 therapy as treatment for B cell lymphoma.
Phase 4 • Sponsor: M.D. Anderson Cancer Center • Aim: Vaccine
Last updated Jun 27, 2026 11:00 UTC
-
New bypass device tested in Real-World leg artery study
Disease control By invitation onlyThe purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% …
Sponsor: Endologix • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can acupressure calm ventilator patients? new trial investigates
Symptom relief CompletedMechanically ventilated intensive care unit (ICU) patients commonly experience agitation, pain, and sleep disturbances, which may negatively affect recovery and increase the need for sedative medications. Non-pharmacological interventions such as acupressure have been proposed as…
Sponsor: Yang Yun Shiuan • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Scientists probe the metabolic side effects of a common diabetes drug
Knowledge-focused Recruiting nowIn this study, we will test the hypothesis that distinct mechanisms account for the SGLT2i-induced stimulation of ketogenesis and lipolysis versus endogenous (hepatic) glucose production in patients with type 2 diabetes (T2D) and type 1 diabetes (T1D), and that the increases in k…
Phase 1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Worldwide registry aims to unlock secrets of tricuspid valve replacement
Knowledge-focused Recruiting nowThe field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necess…
Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:28 UTC
-
VR headsets offer new hope for pandemic PTSD
Symptom relief Recruiting nowHealthcare workers and COVID-19 patients may experience psychological distress consequent to the pandemic, and are at particularly elevated risk for experiencing posttraumatic stress disorder (PTSD), based on evidence from previous infectious disease outbreaks. The best-validated…
Early phase 1 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Can a diabetes drug protect blood vessels in type 1 diabetes?
Disease control Recruiting nowThe investigators will test the hypothesis that, in adults with type 1 diabetes (T1D), glucagon-like peptide-1 receptor agonism (GLP-1RA, i.e. dulaglutide) enhances insulin-mediated skeletal muscle microvascular perfusion via attenuating endothelial oxidative stress and thereby i…
Phase 2 • Sponsor: AdventHealth Translational Research Institute • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New growth hormone drug sogroya® tracked in kids for up to 3 years
Disease control By invitation onlyThe purpose of the study is to investigate the safety and effectiveness of Sogroya® in children with short stature due to growth hormone deficiency where epiphysial discs are not closed under real-world clinical practice in Japan. The study will last for about 1 year (at shortest…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New pain block may cut opioid use after knee surgery
Symptom relief CompletedTotal knee arthroplasty (TKA) is a frequent performed surgery. Many institutions are implementing fast track programs for this surgery and adequate pain management is an important feature. Analgesic duration of single shot nerve blocks is limited to no more than 24h. Conversely, …
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Can special goggles reduce CRPS pain? new study tests prism therapy
Symptom relief CompletedComplex Regional Pain Syndrome (CRPS) is a clinical condition characterized by pain that arises either without an identifiable triggering factor or with a severity disproportionate to the initiating event. Its progression is typically unpredictable, and most therapeutic intervent…
Sponsor: Ankara Etlik City Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Ketamine plus talk therapy: a new hope for stubborn depression?
Disease control CompletedThis pilot study will assess the safety and feasibility of intravenous (IV) ketamine combined with RO DBT in young adults with Treatment-Resistant Depression (TRD). In addition, this study will develop and utilize innovative methodological approaches to demonstrate the feasibilit…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New tool aims to ensure elderly patients get the End-of-Life care they want
Knowledge-focused Recruiting nowPatient-centered medical care considers a patient's values and goals for their health and well-being. Healthcare providers use this information to formulate a medical care plan that is aligned with these expectations. This shared-decision making process should occur with every me…
Sponsor: Royal Victoria Hospital, Canada • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC